Gain Therapeutics (GANX) EPS (Basic) (2020 - 2026)
Gain Therapeutics (GANX) posted EPS (Basic) of -$0.11 for Q2 2026, up 17.9% on a QoQ basis from -$0.13 in Q1 2026, and up 43.05% year-over-year from -$0.08 in Q2 2025.
Powered by 
Analysis
Gain Therapeutics (GANX) EPS (Basic) (2020 - 2026) Analysis & Trends
Gain Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.11 in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 43.05% year-over-year to -$0.11 in Q2 2026; TTM through Jun 2026 was -$0.43, a 38.42% increase from a year earlier, with the FY2025 full-year figure at -$0.55, up 44.95% from the prior year.
- EPS (Basic) was -$0.11 for Q2 2026 at Gain Therapeutics, up from -$0.13 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.08 in Q4 2025, with the low at -$0.62 in Q2 2023.
- Average EPS (Basic) over 5 years is -$0.29, with a median of -$0.27 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) slumped 56.3% in 2023, then surged 69.07% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.39 in 2022, then increased by 2.05% to -$0.39 in 2023, then increased by 28.74% to -$0.27 in 2024, then jumped by 69.07% to -$0.08 in 2025, then slipped by 28.41% to -$0.11 in 2026.
- The last three EPS (Basic) figures came in at -$0.11 (Q2 2026), -$0.13 (Q1 2026), and -$0.08 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Gain Therapeutics | 73.54 Mn | 73.54 Mn | - | -0.11 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.15 |
| Jun 30, 2025 | -0.19 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.42 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.39 |
| Sep 30, 2023 | -0.37 |
| Jun 30, 2023 | -0.62 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | -0.38 |
| Jun 30, 2022 | -0.43 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.32 |
| Sep 30, 2021 | -0.39 |